AU671741B2 - Anthracycline conjugates, their preparation and their use as antitumor agents - Google Patents

Anthracycline conjugates, their preparation and their use as antitumor agents Download PDF

Info

Publication number
AU671741B2
AU671741B2 AU65666/94A AU6566694A AU671741B2 AU 671741 B2 AU671741 B2 AU 671741B2 AU 65666/94 A AU65666/94 A AU 65666/94A AU 6566694 A AU6566694 A AU 6566694A AU 671741 B2 AU671741 B2 AU 671741B2
Authority
AU
Australia
Prior art keywords
gly
document
polymer
anthracycline
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU65666/94A
Other languages
English (en)
Other versions
AU6566694A (en
Inventor
Francesco Angelucci
Maria Grandi
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia SpA filed Critical Pharmacia SpA
Publication of AU6566694A publication Critical patent/AU6566694A/en
Application granted granted Critical
Publication of AU671741B2 publication Critical patent/AU671741B2/en
Assigned to PHARMACIA & UPJOHN S.P.A. reassignment PHARMACIA & UPJOHN S.P.A. Alteration of Name(s) of Applicant(s) under S113 Assignors: PHARMACIA S.P.A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU65666/94A 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents Ceased AU671741B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9309663 1993-05-11
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Publications (2)

Publication Number Publication Date
AU6566694A AU6566694A (en) 1994-12-12
AU671741B2 true AU671741B2 (en) 1996-09-05

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65666/94A Ceased AU671741B2 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Country Status (25)

Country Link
US (1) US5571785A (cg-RX-API-DMAC7.html)
EP (1) EP0649312B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502519A (cg-RX-API-DMAC7.html)
KR (1) KR100330635B1 (cg-RX-API-DMAC7.html)
CN (1) CN1098106C (cg-RX-API-DMAC7.html)
AT (1) ATE203414T1 (cg-RX-API-DMAC7.html)
AU (1) AU671741B2 (cg-RX-API-DMAC7.html)
CA (1) CA2136438C (cg-RX-API-DMAC7.html)
DE (1) DE69427799T2 (cg-RX-API-DMAC7.html)
DK (1) DK0649312T3 (cg-RX-API-DMAC7.html)
ES (1) ES2161764T3 (cg-RX-API-DMAC7.html)
FI (1) FI112602B (cg-RX-API-DMAC7.html)
GB (1) GB9309663D0 (cg-RX-API-DMAC7.html)
GR (1) GR3036978T3 (cg-RX-API-DMAC7.html)
HU (2) HUT70509A (cg-RX-API-DMAC7.html)
IL (1) IL109528A (cg-RX-API-DMAC7.html)
MY (1) MY110974A (cg-RX-API-DMAC7.html)
NZ (1) NZ265266A (cg-RX-API-DMAC7.html)
PL (1) PL175325B1 (cg-RX-API-DMAC7.html)
PT (1) PT649312E (cg-RX-API-DMAC7.html)
RU (1) RU2145965C1 (cg-RX-API-DMAC7.html)
TW (1) TW268015B (cg-RX-API-DMAC7.html)
UA (1) UA42695C2 (cg-RX-API-DMAC7.html)
WO (1) WO1994026311A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943212B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
IL325256A (en) 2014-06-13 2026-02-01 Bach Biosciences Llc FAP-activated medical materials and related uses
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
GB8614323D0 (en) * 1986-06-12 1986-07-16 Erba Farmitalia Anthracyclines
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
DE3722699A1 (de) * 1987-07-09 1989-01-19 Behringwerke Ag Zytostatisch wirksame anthacyclin-konjugate
CA2014244A1 (en) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates

Also Published As

Publication number Publication date
RU2145965C1 (ru) 2000-02-27
HU9403811D0 (en) 1995-03-28
PT649312E (pt) 2002-01-30
FI946128A7 (fi) 1994-12-28
CA2136438A1 (en) 1994-11-24
WO1994026311A1 (en) 1994-11-24
DE69427799T2 (de) 2002-05-02
JPH08502519A (ja) 1996-03-19
NZ265266A (en) 1996-06-25
EP0649312B1 (en) 2001-07-25
GR3036978T3 (en) 2002-01-31
PL306861A1 (en) 1995-04-18
CN1098106C (zh) 2003-01-08
KR950702201A (ko) 1995-06-19
CA2136438C (en) 2004-09-14
ATE203414T1 (de) 2001-08-15
IL109528A (en) 1998-08-16
IL109528A0 (en) 1994-08-26
UA42695C2 (uk) 2001-11-15
KR100330635B1 (ko) 2002-09-17
DE69427799D1 (de) 2001-08-30
AU6566694A (en) 1994-12-12
ZA943212B (en) 1995-01-18
PL175325B1 (pl) 1998-12-31
HU211538A9 (en) 1995-12-28
EP0649312A1 (en) 1995-04-26
DK0649312T3 (da) 2001-11-12
TW268015B (cg-RX-API-DMAC7.html) 1996-01-11
FI946128A0 (fi) 1994-12-28
FI112602B (fi) 2003-12-31
CN1108454A (zh) 1995-09-13
MY110974A (en) 1999-07-31
RU94046336A (ru) 1996-10-27
HUT70509A (en) 1995-10-30
ES2161764T3 (es) 2001-12-16
GB9309663D0 (en) 1993-06-23
US5571785A (en) 1996-11-05

Similar Documents

Publication Publication Date Title
EP0673258B1 (en) Polymer-bound camptothecin derivatives
AU749321B2 (en) Polymeric derivatives of camptothecins
JP4745664B2 (ja) カンプトテシン類の高分子誘導体
JP4039466B2 (ja) 新規アンスラサイクリン系化合物誘導体及びそれを含む医薬製剤
US6376617B1 (en) Bioactive derivatives of camptothecin
EP0649312B1 (en) Anthracycline conjugates, their preparation and their use as antitumor agents
CA2445985A1 (en) Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
KR100348380B1 (ko) 항종양미토크산트론중합체조성물
EP1414792A1 (en) Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
CA1080701A (en) Pharmaceutically active complexes of tetracyclines and a process for the preparation thereof
MXPA00003031A (en) Polymeric derivatives of camptothecins
WO2019163958A1 (ja) 薬物複合体、ミセル、及び医薬組成物